-
Seven patients were identified when DAP-ASBL therapy was used to eradicate persistent MRSA bacteremia. Isolates from 3 patients were available for in vitro study.
-
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.
-
The National Medication Error Reporting Program (operated by the Institute for Safe Medication Practices [ISMP]) recently issued an alert on the potential risk of medication errors associated with dosing colistimethate for injection.
-
-
The American Medical Association convened the biannual House of Delegates meeting in Chicago in June with more than 500 delegates from a variety of societies and organizations.
-
-
In this issue: Apixaban could soon join the anticoagulation market; Chinese herbs for flu; chronic medication and discontinuation after hospitalization; and FDA actions.
-
In Part 1 of this two-part series on Pregnancy and Critical Care Medicine (see Critical Care Alert, March 2011, p. 89-93), we reviewed the normal physiologic changes that occur during pregnancy, examining changes occurring across multiple organ systems that affect our management of these patients as well as the ability of the pregnant woman to respond to various forms of stress, such as acute hemorrhage.
-
-
In this prospective study carried out in a 13-bed French medical ICU, Thille and associates sought to determine the clinical characteristics and outcomes of patients who experienced extubation failure the requirement for reintubation within 72 hours of either planned or unplanned extubation.
